drugset / Trial / NCT04977674
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
RandomizedCrossoverQuadruple-blindBasic science
Summary
The overarching aim of this research is to determine the acute effects of ketamine on brain glutamate, functional connectivity and cerebral blood flow in treatment-resistant depression, explore whether the effects are attenuated by the opioid receptor antagonist naltrexone and relate these findings to antidepressant response.
Timeline
- Start
- 2021-09-27
- Primary completion
- 2023-02-13
- Completion
- 2023-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Naltrexone | Small molecule | 50 mg | Oral |